The avian influenza H5N1 virus strain is the leading candidate to cause the next avian influenza pandemic. This study will test the safety and immunogenicity of a H5N1 pandemic influenza vaccine in healthy adults.
Official Title
Phase Ia Study of a Pandemic Influenza Vaccine
Conditions
Avian Influenza
Study Type
Interventional
Study Design
Prevention, Randomized, Single Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study
Further Details
- Primary Outcome Measures:Safety and immunogenicity
Study Start
October 2005; Study completion: November 2006
Eligibility & Criteria
- Ages Eligible for Study: 18 Years – 45 Years
- Genders Eligible for Study: Both
Inclusion Criteria:
- Healthy adults
Exclusion Criteria:
- History of Guillain-Barre syndrome or active neurological disease
Total Enrolment
400
Contact Details
Terry M Nolan, Principal Investigator, Murdoch Childrens Research Institute
- Murdoch Childrens Research Institute, Melbourne, Victoria, 3052, Australia
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
Related Articles
Need a health appointment?
Find and book a doctor, dentist, physio and more on Healthengine
Find a practitioner
